Tofacitinib, an oral Janus kinase inhibitor, as monotherapy or with background methotrexate, in Japanese patients with rheumatoid arthritis: an open-label, long-term extension study

RT @CAPA_Arthritis: Tofacitinib, an oral Janus kinase inhibitor, as monotherapy/with background methotrexate in RA https://t.co/MnjiSH4OLC…

Tofacitinib, an oral Janus kinase inhibitor, as monotherapy/with background methotrexate in RA https://t.co/MnjiSH4OLC #sjogrens #rheum

Tofacitinib, an oral Janus kinase inhibitor, as monotherapy or with background methotrexate in RA https://t.co/XJUDB2JEGe #sjogrens #rheum